Transcode Therapeutics Inc
RNAZLatest QuantConomy context for RNAZ: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Transcode Therapeutics Inc
QuantConomy has a structured record for RNAZ. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- RNAZ
- Name
- Transcode Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for RNAZ
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| other event | neutral | 70 | Jul 2, 08:31 PM | RNAZ filed 8-K: Other Events - 1 material event - [strong neutral signal] |
| eps change | very bullish | 76 | May 15, 12:00 AM | RNAZ (Q1 2026, diluted eps): EPS grew 59.5% ($-52.59 → $-21.28). [sequential period basis, very bullish signal] |
| operating income change | bullish | 69 | May 15, 12:00 AM | RNAZ (Q1 2026, operating income): grew 36.5% (-$27.98M → -$17.76M). [sequential period basis, bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| RNAZ | NASDAQ | alphavantage | TransCode Therapeutics Inc |
| RNAZ | NASDAQ | alpaca | TransCode Therapeutics, Inc. Common Stock |
| RNAZ | NASDAQ | fmp | TransCode Therapeutics, Inc. |
Recent insider transactions
No recent Form 3, 4, or 5 insider transaction rows were returned for RNAZ.
Source: SEC filings via QuantConomy. Not investment advice.
Query RNAZ context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access